Top Markets
Coin of the day
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rang in aandelen #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Aandeelprijs
$48.45
Marktkapitalisatie
$1.39B
Verandering (1 dag)
1.16%
Verandering (1 jaar)
-
Land
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Categorie

Koersgeschiedenis voor LB Pharmaceuticals Inc Common Stock (LBRX)
Hoogste slotkoers: $47.36 op 2026-08-01

Laagste slotkoers: $15.87 op 2025-09-01
Koersgeschiedenis van LB Pharmaceuticals Inc Common Stock van 2025 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 24.35%
2025 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$542.09 38.27%
US
$1.03K 45.80%
NL
$121.53 -12.48%
AU
$138.18 464.67%
US
$759.27 6.90%
CH